Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer

Clinical patterns and the associated optimal management of acquired resistance to PD-(L)1 blockade are poorly understood. All cases of metastatic lung cancer treated with PD-(L)1 blockade at Memorial Sloan Kettering were reviewed. In acquired resistance (complete/partial response per RECIST, followe...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical cancer research Ročník 28; číslo 17; s. 3797
Hlavní autori:	Schoenfeld, Adam J, Rizvi, Hira A, Memon, Danish, Shaverdian, Narek, Bott, Matthew J, Sauter, Jennifer L, Tsai, C Jillian, Lihm, Jayon, Hoyos, David, Plodkowski, Andrew J, Perez-Johnston, Rocio, Sawan, Peter, Egger, Jacklynn V, Greenbaum, Benjamin D, Rimner, Andreas, Riely, Gregory J, Rudin, Charles M, Rusch, Valerie W, Gomez, Daniel R, Hellmann, Matthew D
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.09.2022
Predmet:	B7-H1 Antigen Biomarkers, Tumor - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Humans Immunotherapy Lung Neoplasms - pathology Tumor Burden
ISSN:	1557-3265, 1557-3265
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!